The ROE as of November 2024 (TTM) for Adaptive Biotechnologies Corporation (ADPT) is -71.96%

According to Adaptive Biotechnologies Corporation’s latest financial reports and current stock price. The company's current ROE is -71.96%. This represents a change of 295.19% compared to the average of -18.21% of the last 4 quarters.

Adaptive Biotechnologies Corporation (ADPT) Historical ROE (quarterly & annually)

How has ADPT ROE performed in the past?

The mean historical ROE of Adaptive Biotechnologies Corporation over the last ten years is -18.54%. The current -71.96% ROE has changed 288.07% with respect to the historical average. Over the past ten years (40 quarters), ADPT's ROE was at its highest in in the June 2019 quarter at 5.51%. The ROE was at its lowest in in the December 2023 quarter at -22.52%.

Adaptive Biotechnologies Corporation (ADPT) ROE by Quarter and Year

Discovering the peaks and valleys of Adaptive Biotechnologies Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adaptive Biotechnologies Corporation (ADPT) Average ROE

How has ADPT ROE performed in the past?

The current ROE of Adaptive Biotechnologies Corporation (ADPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Adaptive Biotechnologies Corporation (ADPT) ROE vs. Peers

How is ADPT’s ROE compared to its peers?

Adaptive Biotechnologies Corporation’s ROE is greater than Verve Therapeutics, Inc. (-35.20%), greater than Beam Therapeutics Inc. (-16.22%), greater than Caribou Biosciences, Inc. (-34.76%), greater than Sana Biotechnology, Inc. (-71.60%), greater than VectivBio Holding AG (-56.92%), greater than Kinnate Biopharma Inc. (-59.00%), less than Royalty Pharma plc (10.50%), greater than Ikena Oncology, Inc. (-42.81%), greater than CohBar, Inc. (-58.44%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), greater than Rain Therapeutics Inc. (-81.52%), less than Krystal Biotech, Inc. (13.36%), less than AVROBIO, Inc. (29.68%), greater than Enveric Biosciences, Inc. (-234.16%), greater than Elevation Oncology, Inc. (-57.97%), greater than Zura Bio Limited (-35.45%), greater than Reneo Pharmaceuticals, Inc. (-62.53%), greater than Legend Biotech Corporation (-23.20%), greater than Vir Biotechnology, Inc. (-36.71%), greater than Apellis Pharmaceuticals, Inc. (-139.02%),

Build a custom stock screener for Adaptive Biotechnologies Corporation (ADPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adaptive Biotechnologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adaptive Biotechnologies Corporation (ADPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adaptive Biotechnologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.